Quick Answer
Nurix Therapeutics, Inc. reported Common Stock Shares Outstanding of 101.81 million shares for the year ending 2025.
- Nurix Therapeutics, Inc. showed an increase of +34.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Nurix Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on January 28, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Nurix Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 2,731.7%.
- Historical annual values: Fiscal year 2025: 101.81 million shares | Fiscal year 2024: 75.87 million shares | Fiscal year 2023: 48.72 million shares | Fiscal year 2022: 47.17 million shares | Fiscal year 2021: 44.66 million shares | Fiscal year 2020: 38.86 million shares | Fiscal year 2019: 3.60 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: